BIOTRICITY INC (BTCY) Forecast, Price Target & Analyst Ratings
NASDAQ:BTCY • US09074H2031
0.4631 USD
-0.18 (-28.31%)
At close: Aug 2, 2024
0.431 USD
-0.03 (-6.93%)
After Hours: 8/2/2024, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOTRICITY INC (BTCY).
Forecast Snapshot
Consensus Price Target
$4.08
+ 781.02% Upside
Next Earnings Forecast
Release DateAug 12, 2024
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.08
Upside
+ 781.02%
From current price of $0.46 to mean target of $4.08, Based on 6 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for BTCY. The average price target is 4.08 USD. This implies a price increase of 781.02% is expected in the next year compared to the current price of 0.4631.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
BTCY was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BTCY.
In the previous month the buy percentage consensus was at a similar level.
BTCY was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-11-20 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-07-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-15 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-07-15 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-07-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-07 | Lake Street | Initiate | Buy |
| 2021-11-23 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 12, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 7.65M 126.33% | 9.64M 26.01% | 12.063M 25.14% | 14.586M 20.91% | |
| EBITDA YoY % growth | -17.47M | -13.61M 22.10% | -5.804M 57.36% | N/A | |
| EBIT YoY % growth | -17.47M -35.74% | -13.62M 22.04% | -5.809M 57.35% | -8.466M -45.73% | |
| Operating Margin | -228.37% | -141.29% | -48.16% | -58.04% | |
| EPS YoY % growth | -1.61 | -2.24 -39.38% | -1.66 26.07% | -0.44 73.56% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOTRICITY INC / BTCY Forecast FAQ
Can you provide the average price target for BIOTRICITY INC stock?
6 analysts have analysed BTCY and the average price target is 4.08 USD. This implies a price increase of 781.02% is expected in the next year compared to the current price of 0.4631.
Can you provide the upcoming earnings date for BIOTRICITY INC?
BIOTRICITY INC (BTCY) will report earnings on 2024-08-12, after the market close.
What is the consensus rating for BIOTRICITY INC (BTCY) stock?
The consensus rating for BIOTRICITY INC (BTCY) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.